BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit

Core Insights - BioRestorative Therapies, Inc. is participating in the 2025 Maxim Growth Summit on October 22nd to 23rd, focusing on regenerative medicine and stem cell therapies [1][2] - The company's management will engage in a panel discussion on stem cell therapy and hold one-on-one meetings with institutional investors [2] Company Overview - BioRestorative develops therapeutic products utilizing adult stem cells, with two main clinical programs targeting disc/spine disease and metabolic disorders [3] - The lead candidate, BRTX-100, is designed for non-surgical treatment of lumbosacral disc disorders, currently in Phase 2 clinical trials for chronic lower back pain [3] - The Metabolic Program, ThermoStem, focuses on using brown adipose-derived stem cells to combat obesity and metabolic disorders, with promising preclinical results [4] - The company also operates a BioCosmeceutical platform, offering a cell-based secretome product aimed at cosmetic improvements, with plans for further product development [5]